| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |